Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] The company operates in a highly competitive and fragmented segment with many players around. The sudden boost in its bottom line for 10M- FY23 raise eyebrows and concern over the sustainability going forward. Based on such super earnings, the issue appears aggressively priced while based on its track records so far, the issue is exorbitantly priced. Tiny equity capital post-IPO indicates a longer gestation period for migration to the mainboard. There is no harm in skipping this pricey issue. Read detail review...
AccelerateBS IPO Reviews, analysis and views by popular members. Read AccelerateBS India Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
RHP